Moderna completes $3.0B convertible notes offering due 2032

Moderna completed a $3.0 billion private offering of 0.00% Convertible Senior Notes due March 1, 2032 and executed the related indenture.

The notes, initially convertible at $210.58 per share, provide flexibility for settlement in cash, stock, or a combination.

To mitigate dilution from potential c…